Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Without An Alzheimer’s Blockbuster, Biogen Is A Ship Without A Growth Rudder
Lecanemab Phase III Readout Next Major Milestone
Jul 20 2022
•
By
Mandy Jackson
Biogen is trying to navigate its way back to revenue growth • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business